| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/0190-9622(95)91818-3 |
| P953 | full work available at URL | https://api.elsevier.com/content/article/PII:0190962295918183?httpAccept=text/xml |
| https://api.elsevier.com/content/article/PII:0190962295918183?httpAccept=text/plain | ||
| P698 | PubMed publication ID | 7593780 |
| P2093 | author name string | G. R. Kantor | |
| H. Menduke | |||
| C. S. Connolly | |||
| P2860 | cites work | Cholestatic pruritus | Q5104315 |
| A multicenter, controlled trial of ursodiol for the treatment of primary biliary cirrhosis. UDCA-PBC Study Group | Q28243457 | ||
| Subhypnotic doses of propofol relieve pruritus associated with liver disease | Q39496761 | ||
| Treatment of pruritus of primary biliary cirrhosis with rifampin | Q39511303 | ||
| Rifampin relieves pruritus in children with cholestatic liver disease | Q42113044 | ||
| Treatment of pruritus due to chronic obstructive liver disease | Q42174795 | ||
| Effect of ursodeoxycholic acid on bile acid metabolism in primary biliary cirrhosis. | Q42199158 | ||
| A prospective trial of colchicine for primary biliary cirrhosis | Q42659809 | ||
| Double blind controlled trial of d-penicillamine in patients with primary biliary cirrhosis | Q43214926 | ||
| Naloxone modulates the perception of itch in man. | Q43243843 | ||
| Pruritus, Cimetidine and Polycythemia | Q44332964 | ||
| Comparison of rifampicin with phenobarbitone for treatment of pruritus in biliary cirrhosis. | Q44573504 | ||
| Failure of rifampin to relieve pruritus in chronic liver disease | Q45156021 | ||
| Ursodiol for the long-term treatment of primary biliary cirrhosis. The UDCA-PBC Study Group. | Q54118475 | ||
| Identifying effective treatments for uremic pruritus | Q67907254 | ||
| A multi-center double-blind controlled trial of ursodeoxycholic acid for primary biliary cirrhosis | Q68166227 | ||
| A controlled trial of cyclosporine in the treatment of primary biliary cirrhosis | Q68505504 | ||
| Oral S-adenosylmethionine in the symptomatic treatment of intrahepatic cholestasis. A double-blind, placebo-controlled study | Q68512879 | ||
| A controlled trial of colchicine in primary biliary cirrhosis. Trial design and preliminary report | Q69401293 | ||
| A pilot, double-blind, controlled 1-year trial of prednisolone treatment in primary biliary cirrhosis: hepatic improvement but greater bone loss | Q69721905 | ||
| Double-blind placebo-controlled clinical trial of microporous cholestyramine in the treatment of intra- and extra-hepatic cholestasis: relationship between itching and serum bile acids | Q70416879 | ||
| Ursodeoxycholic acid in the treatment of primary biliary cirrhosis | Q72401649 | ||
| Ursodeoxycholic acid for symptomatic primary biliary cirrhosis. Preliminary analysis of a double-blind multicenter trial. Italian Multicenter Group for the Study of UDCA in PBC | Q72789964 | ||
| P433 | issue | 5 Pt 1 | |
| P407 | language of work or name | English | Q1860 |
| P1104 | number of pages | 5 | |
| P304 | page(s) | 801-805 | |
| P577 | publication date | 1995-11-01 | |
| P1433 | published in | Journal of the American Academy of Dermatology | Q15757046 |
| P1476 | title | Hepatobiliary pruritus: what are effective treatments? | |
| Hepatobiliary pruritus: What are effective treatments? | |||
| P478 | volume | 33 |
| Q34281819 | Ethnicity-dependent polymorphism in Na+-taurocholate cotransporting polypeptide (SLC10A1) reveals a domain critical for bile acid substrate recognition | cites work | P2860 |
Search more.